[VRDN] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -12.72%
YoY- -149.50%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 216 1,451 828 372 4,784 462 818 -19.89%
PBT -25,693 -18,460 -8,044 -11,629 -4,661 -6,980 -2,758 45.03%
Tax -196 55 27 339 167 30 0 -
NP -25,497 -18,460 -8,044 -11,629 -4,661 -6,980 -2,758 44.84%
Tax Rate - - - - - - - -
Total Cost 25,713 19,911 8,872 12,001 9,445 7,442 3,576 38.90%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -11,804.17 -1,272.23 -971.50 -3,126.08 -97.43 -1,510.82 -337.16 80.82%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.98 -2.91 -2.65 -5.65 -2.64 -9.06 -3.85 -20.38%
EPS Diluted -0.98 -2.91 -2.65 -5.65 -2.64 -9.06 -3.85 -20.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.